logologo
QuantliQuantli
PB

Parabilis Medicines Inc

PBLS

NASDAQ

Biotechnology

$37.07

USD

+1.40 (+3.92%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $0

Volume 290.9K

Price Target

$40.00$45.00

USD

The 3 analysts offering 1-year price forecasts have a max estimate of $45.00 and a min estimate of $40.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$41.67

Implied Upside

+12.4%

Analyst Covering

3

Consensus

Buy

Signal Quality

Consensus Freshness

100%

Most ratings are recent - from the last 3 months

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$1.67 Gap

Median $40.00 vs avg $41.67 - a few bullish outliers are pulling the average up

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

3 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

3 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Tazeen Ahmad

B of A Securities

Buy

Initiated

1 month ago

Plus
Plus
Plus

Michael Schmidt

Guggenheim

Buy

Initiated

1 month ago

Plus
Plus
Plus

Andrew Berens

Leerink Partners

Buy

Initiated

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

ACAD

ACADIA Pharmaceuticals Inc

$28.24

-0.5%

RLAY

Relay Therapeutics Inc

$19.86

-0.3%

CELC

Celcuity Inc

$92.00

+6.2%

DYN

Dyne Therapeutics, Inc

$25.70

-1.0%

DNLI

Denali Therapeutics Inc

$24.40

-1.7%

LEGN

Legend Biotech Corp

$20.37

+0.5%

VKTX

Viking Therapeutics Inc

$33.19

+0.8%

TNGX

Tango Therapeutics Inc

$25.60

-0.2%